Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages

  Seinen, M L ^a   De Boer, N K H ^a   Van Hoorn, M E ^a   Van Bodegraven, A A ^a   Bouma, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLTHIOINOSINE; ALLOPURINOL; CALGRANULIN; MERCAPTOPURINE; MESALAZINE;

ADULT; BLEEDING; CASE REPORT; CESAREAN SECTION; DIARRHEA; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; DRUG USE; ECHOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HUMAN; LETTER; LOW DRUG DOSE; PREGNANCY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADULT; ALLOPURINOL; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84876406669     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22945     Document Type: Letter

References (8)

1. Jharap B, Seinen ML, de Boer NK, et al. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts. Inflamm Bowel Dis. 2010;16:1541-1549.
2. Ansari A, Patel N, Sanderson J, et al. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2010;31:640-647.
3. Sparrow MP, Hande SA, Friedman S, et al. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5:209-214.
4. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel in adults. Gut. 2011;60:571-607.
5. de Boer NK, Jarbandhan SV, de Graaf P, et al. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol. 2006;101:1390-1392.
6. Jharap B, de Boer NK, van der Woude CJ, et al. Thiopurine metabolite measurements during pregnancy in mother and child. J Crohns Colitis Suppl. 2008;2:32 [abstract].
7. Kozenko M, Grynspan D, Oluyomi-Obi T, et al. Potential teratogenetic effects of allopurinol: a case report. Am J Med Genet Part A. 2011;155:2247-2252.
8. Kaandorp JJ, Benders MJNL, Rademaker CMA, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth. 2010;18:8.